SYN-TECH Chem. & Pharm. Income Statement

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	1,300	1,258	1,115	986.3	893.23
Revenue Growth (YoY)	3.38%	12.83%	13.02%	10.42%	-9.21%
Cost of Revenue	849.88	770.72	705.17	618.3	601.88
Gross Profit	450.36	486.94	409.52	368	291.35
Selling, General & Admin	91.63	93.45	89.73	89.91	86.29
Research & Development	38.87	42.51	37.91	39.86	36.48
Operating Expenses	130.5	136.14	127.67	129.77	122.77
Operating Income	319.86	350.8	281.85	238.23	168.59
Interest Expense	-1	-2.14	-5.74	-5.92	-3.39
Interest & Investment Income	16.89	20.31	29.73	16.01	2.26
Earnings From Equity Investments	-	-	0.7	-11.59	-0.73
Currency Exchange Gain (Loss)	-	42.97	2.57	89.96	-18.79
Other Non Operating Income (Expenses)	-1.83	7.35	5.42	34.99	119.22
EBT Excluding Unusual Items	333.92	419.29	314.53	361.68	267.15
Gain (Loss) on Sale of Investments	-	-0.78	-	-6.15	-
Gain (Loss) on Sale of Assets	-	-5.48	-0.77	-0.3	-0.73
Other Unusual Items	-	-	-	-	-237.39
Pretax Income	333.92	488.24	313.77	355.24	200.23
Income Tax Expense	72.31	94.95	62.76	59.95	23.07
Net Income	261.61	393.28	251.01	295.29	177.16
Net Income to Common	261.61	393.28	251.01	295.29	177.16
Net Income Growth	-33.48%	56.68%	-14.99%	66.68%	-5.13%
Shares Outstanding (Basic)	45	45	45	45	35
Shares Outstanding (Diluted)	45	45	45	45	35
Shares Change (YoY)	0.05%	0.03%	0.05%	26.57%	17.18%
EPS (Basic)	5.87	8.82	5.63	6.62	5.03
EPS (Diluted)	5.85	8.80	5.62	6.61	5.02
EPS Growth	-33.52%	56.58%	-14.98%	31.67%	-19.03%
Free Cash Flow	501.19	408.92	-175.05	-38.59	24.93
Free Cash Flow Per Share	11.21	9.15	-3.92	-0.86	0.71
Dividend Per Share	-	5.300	3.500	3.000	2.150
Dividend Growth	-	51.43%	16.67%	39.53%	-46.25%
Gross Margin	34.64%	38.72%	36.74%	37.31%	32.62%
Operating Margin	24.60%	27.89%	25.29%	24.15%	18.87%
Profit Margin	20.12%	31.27%	22.52%	29.94%	19.83%
Free Cash Flow Margin	38.55%	32.51%	-15.70%	-3.91%	2.79%
EBITDA	467	491.55	390.36	316.24	237.6
EBITDA Margin	35.92%	39.09%	35.02%	32.06%	26.60%
D&A For EBITDA	147.14	140.75	108.51	78.01	69.01
EBIT	319.86	350.8	281.85	238.23	168.59
EBIT Margin	24.60%	27.89%	25.29%	24.15%	18.87%
Effective Tax Rate	21.65%	19.45%	20.00%	16.88%	11.52%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.